Corrigendum: Intratumor tertiary lymphatic structure evaluation predicts the prognosis and immunotherapy response of patients with colorectal cancer

oleh: Huijing Feng, Siyuan Zhang, Siyuan Zhang, Siyuan Zhang, Siyuan Zhang, Siyuan Zhang, Qiuru Zhou, Qiuru Zhou, Qiuru Zhou, Qiuru Zhou, Qiuru Zhou, Qiuru Zhou, Fei Han, Gang Du, Lin Wang, Xuena Yang, Xuena Yang, Xuena Yang, Xuena Yang, Xuena Yang, Xiying Zhang, Xiying Zhang, Xiying Zhang, Xiying Zhang, Xiying Zhang, Wenwen Yu, Wenwen Yu, Wenwen Yu, Wenwen Yu, Wenwen Yu, Feng Wei, Feng Wei, Feng Wei, Feng Wei, Feng Wei, Feng Wei, Xishan Hao, Xishan Hao, Xishan Hao, Xishan Hao, Xishan Hao, Xiubao Ren, Xiubao Ren, Xiubao Ren, Xiubao Ren, Xiubao Ren, Xiubao Ren, Xiubao Ren, Hua Zhao, Hua Zhao, Hua Zhao, Hua Zhao, Hua Zhao, Hua Zhao

Format: Article
Diterbitkan: Frontiers Media S.A. 2024-06-01

Deskripsi

Subjek

TLS; CRC; dMMR; PMMR; anti-PD1 immunotherapy